Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype

Anticancer Research

Volumn 31, Issue 6, 2011, Pages 2367-2371

  Amant, Frédéric ^a   Tousseyn, Thomas ^a   Coenegrachts, Lieve ^a   Decloedt, Jan ^b   Moerman, Philippe ^a   Debiec Rychter, Maria ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b St Blasius Hospital   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Endometrial stromal sarcoma; Neuroectodermal; T(10; 17) translocation

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 17; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ECHOGRAPHY; ENDOMETRIAL STROMAL TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROECTODERM TUMOR; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALPINGOOOPHORECTOMY; THROMBOCYTOSIS; UTERUS BLEEDING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; NEUROECTODERMAL TUMORS; PHENOTYPE; SARCOMA, ENDOMETRIAL STROMAL; TRANSLOCATION, GENETIC; UTERINE NEOPLASMS;

EID: 79960460351     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Amant F, Coosemans A, Debiec-Rychter M, Timmerman D and Vergote I: Clinical management of uterine sarcomas. Lancet Oncol 10: 1188-1198, 2009.
2. Norris HJ and Taylor HB: Postirradiation sarcomas of the uterus. Obstet Gynecol 26: 689-694, 1965.
3. Oliva E, Clement PB and Young RH: Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7: 257-281, 2000.
4. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL and Hendrickson MR: Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14: 415-438, 1990.
5. Loddenkemper C, Mechsner S, Foss HD, Dallenbach FE, Anagnostopoulos I, Ebert AD and Stein H: Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol 27: 1458-1462, 2003.
6. Oliva E, Young RH, Amin MB and Clement PB: An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26: 403-412, 2002.
7. Zhu XQ, Shi YF, Cheng XD, Zhao CL and Wu YZ: Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol 92: 71-79, 2004.
8. Amant F, Vergote I and Moerman P: The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. Gynecol Oncol 95: 412-413, 2004.
9. Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50: 2170-2182, 1982.
10. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C and Triche TJ: The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331: 294-299, 1994.
11. Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG and Malpica A: Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 32: 219-228, 2008.
12. Micci F and Heim S: Pathogenetic mechanisms in endometrial stromal sarcoma. Cytogenet Genome Res 118: 190-195, 2007.
13. Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den BH, Dal CP, Fletcher JA and Sklar J: Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98: 6348-6353, 2001.
14. Micci F, Panagopoulos I, Bjerkehagen B and Heim S: Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66: 107-112, 2006.
15. Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, Schoenmakers EF and Vergote I: Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. Gynecol Oncol 91: 265-271, 2003.
16. Micci F, Walter CU, Teixeira MR, Panagopoulos I, Bjerkehagen B, Saeter G and Heim S: Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet 144: 119-124, 2003.
17. Regauer S, Emberger W, Reich O and Pfragner R: Cytogenetic analyses of two new cases of endometrial stromal sarcoma-non-random reciprocal translocation t(10;17)(q22;p13) correlates with fibrous ESS. Histopathology 52: 780-783, 2008.
18. Mitelman F, Johansson B and Mertens F (eds). Mitelman Database of Chromosome Aberrations in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman, 2010.